{"nct_id":"NCT03580369","title":"A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines","status":"COMPLETED","status_verified_date":"2023-07","start_date":"2018-10-17","start_date_type":"ACTUAL","primary_completion_date":"2021-07-16","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}